EUVIMEDEUVIMED entdecken
Multizentrische StudieVideo/Audio

Endoscopic submucosal dissection of appendicular lesions is feasible and safe: a retrospective multicenter study (with video)

Mariana Figueiredo, Clara Yzet, Timothée Wallenhorst, Jérôme Rivory, Florian Rostain, Marion Schaefer, Jean-Baptiste Chevaux, Sarah Leblanc, Vincent Lépilliez, Felix Corre, Gabriel Rahmi, Jérémie Jacques und 2 weitere

Gastrointestinal Endoscopy · 2023

DOI: 10.1016/j.gie.2023.06.024 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Gastrointestinal Endoscopy, 2023. Verfasst von Mariana Figueiredo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy and Gastroenterology Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Appendix. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is challenging for appendicular lesions. We report the outcomes of ESD in this context. METHODS: We collected data of ESD procedures for appendiceal neoplasia in a multicenter prospective registry. Main study endpoints were R0, en-bloc, and curative resection rates and adverse event rate. RESULTS: One hundred twelve patients were included, 47 (42%) with previous appendectomy. Fifty-six (50%) were Toyonaga type 3 lesions (15 [13.4%] postappendectomy). En-bloc and R0 resection rates were 86.6% and 80.4%, respectively, with no significant difference associated with different grades of appendiceal invasion (P = .9 and P = .4, respectively) or previous appendectomy (P = .3 for both). The curative resection rate was 78.6%. Additional surgery was performed in 16 cases (14.3%), including 10 (62.5%) Toyonaga type 3 lesions (P = .04). This included the treatment of 5 cases (4.5%) of delayed perforation and 1 acute appendicitis. CONCLUSIONS: ESD for appendicular lesions is a potentially safer and effective alternative to surgery for a significant proportion of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionAppendixHumansRetrospective StudiesAppendectomyTreatment Outcome

Autor:innen und Institutionen

  • Endoscopy and Gastroenterology Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
  • Endoscopy and Gastroenterology Unit, Pontchaillou University Hospital, Rennes, France.
  • Endoscopy and Gastroenterology Unit, Nancy University Hospital, Nancy, France.
  • Department of Endoscopy and Gastroenterology, Hôpital Privé Jean Mermoz, Lyon, France.
  • Endoscopy and Gastroenterology Unit, Hôpital Cochin, Paris, France.
  • Gastroenterology and Endoscopy Unit, Hôpital Européen Georges Pompidou, Paris, France.

Zitieren

APA

Figueiredo, M., Yzet, C., Wallenhorst, T., Rivory, J., Rostain, F., Schaefer, M., Chevaux, J. B., Leblanc, S., Lépilliez, V., Corre, F., Rahmi, G., Jacques, J., Albouys, J., & Pioche, M. (2023). Endoscopic submucosal dissection of appendicular lesions is feasible and safe: a retrospective multicenter study (with video). Gastrointestinal Endoscopy. https://doi.org/10.1016/j.gie.2023.06.024

Vancouver

Figueiredo M, Yzet C, Wallenhorst T, Rivory J, Rostain F, Schaefer M, et al. Endoscopic submucosal dissection of appendicular lesions is feasible and safe: a retrospective multicenter study (with video). Gastrointestinal Endoscopy. 2023. doi:10.1016/j.gie.2023.06.024

BibTeX
@article{Figueiredo2023,
  author = {Figueiredo, Mariana and Yzet, Clara and Wallenhorst, Timothée and Rivory, Jérôme and Rostain, Florian and Schaefer, Marion and Chevaux, Jean-Baptiste and Leblanc, Sarah and Lépilliez, Vincent and Corre, Felix and Rahmi, Gabriel and Jacques, Jérémie and Albouys, Jérémie and Pioche, Mathieu},
  title = {Endoscopic submucosal dissection of appendicular lesions is feasible and safe: a retrospective multicenter study (with video)},
  journal = {Gastrointestinal Endoscopy},
  year = {2023},
  doi = {10.1016/j.gie.2023.06.024}
}
Kostenlos starten →